Analyst Price Targets — CURI
| Date | Analyst | Firm | Target | Price @ Post | Source | Headline |
|---|---|---|---|---|---|---|
| October 28, 2025 12:07 pm | Patrick Sholl | Barrington | $6.00 | $4.47 | StreetInsider | Barrington Research Upgrades CuriosityStream Inc. (CURI) to Outperform |
| June 28, 2022 8:28 am | — | Stifel Nicolaus | $2.00 | $1.99 | Benzinga | Stifel Maintains Hold on CuriosityStream, Lowers Price Target to $2 |
| May 13, 2022 6:01 am | — | Needham | $3.00 | $1.86 | Benzinga | Needham Maintains Buy on CuriosityStream, Lowers Price Target to $3 |
Latest News for CURI
SILVER SPRING, MD / ACCESS Newswire / March 16, 2026 / CuriosityStream, Inc. (the "Company") (Nasdaq:CURI), a leading global factual entertainment media company, today announced that Clint Stinchcomb, President and CEO will be participating in 1x1 meetings at the 38th Annual ROTH Conference: Event: 38th Annual ROTH ConferenceDate: March 22-24, 2026Format: 1x1 MeetingsLocation: The Ritz-Carlton Laguna Niguel, Dana…
CuriosityStream Inc. (CURI) Q4 2025 Earnings Call Transcript
CuriosityStream Inc. (CURI) came out with a quarterly loss of $0.06 per share versus the Zacks Consensus Estimate of a loss of $0.04. This compares to a loss of $0.05 per share a year ago.
Full year 2025 revenue of $71.7 million, up 40% Record full-year operating cash flow of $13.1 million, up 60% Board authorizes $6 million share repurchase SILVER SPRING, MD / ACCESS Newswire / March 11, 2026 / CuriosityStream Inc. (Nasdaq:CURI), a global factual entertainment company, today announced its financial results for the fourth quarter and fiscal year ended December 31, 2025. In addition, the Company's…
CuriosityStream Inc. (NASDAQ: CURI - Get Free Report) has received an average rating of "Moderate Buy" from the six analysts that are covering the firm, Marketbeat.com reports. One research analyst has rated the stock with a sell recommendation, one has assigned a hold recommendation, three have issued a buy recommendation and one has issued a strong
🧮 Earnings Move Analyzer
Insider Trading
Insider Trading
| Name | Role | Date | Type | Shares | Price | Form | Link |
|---|
Senate Trading
No Senate trades found for CURI.
U.S. House Trading
No House trades found for CURI.
Options Chain
Select an expiration to expand. Bid/Ask are shown first (before Mark) on both sides.